Active, not recruitingNCT04515524
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
Studying Retinopathy of prematurity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Regeneron Pharmaceuticals
- Principal Investigator
- Clinical Trial ManagementRegeneron Pharmaceuticals
- Intervention
- Non-Interventional(other)
- Enrollment
- 100 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2021 – 2026
Study locations (30)
- UCSD Shiley Eye Institute, Jacobs Retina Center, La Jolla, California, United States
- Loma Linda University Eye Institute, Loma Linda, California, United States
- University of California San Francisco - Ophthalmology, San Francisco, California, United States
- New York University School of Medicine - Oncology, New York, New York, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
- Lifespan - Women & Infants Hospital of RI, Providence, Rhode Island, United States
- The Children's Hospital of San Antonio, San Antonio, Texas, United States
- West Virginia University, Morgantown, West Virginia, United States
- Acibadem City Clinic Multiprofile Hospital for Active Treatment, Sofia, Bulgaria
- Specialized Hospital for Active Treatment of Eye Diseases - Varna, Varna, Bulgaria
- Clinica Universitaria Bolivariana, Medellín, Antioquia, Colombia
- Fundacion Oftalmologica de Santander Foscal, Floridablanca, Santander Department, Colombia
- SC Centrul Medical Unirea SRL, Iași, Romania
- V.F. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children - ophtalmology, Moscow, Moscow, Russia
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04515524 on ClinicalTrials.govOther trials for Retinopathy of prematurity
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07093255Safety, PK and PD of FLQ-101 in Premature NeonatesFELIQS INC.
- RECRUITINGNCT06612541Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of PrematurityVanderbilt University Medical Center
- ENROLLING BY INVITATIONNANCT07334652Pain and Comfort in the Examination of Retinopathy of PrematurityAtaturk University
- RECRUITINGNANCT06717412Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity TherapyWang Yusheng
- RECRUITINGNCT05558059Imaging Retinal Vasculature in Infant EyesDuke University
- ACTIVE NOT RECRUITINGNANCT06109285Validation of i-ROP DL to Detect More Than Mild ROPSiloam Vision
- RECRUITINGNCT06315556An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)Bayer
- RECRUITINGNANCT06694103The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy ExaminationSinem Basdemir